Philips signs agreement with Novation
Under an agreement signed at the end of last month, Philips Medical Systems will supply general radiology equipment to Novation, supplier of medical equipment to Voluntary Hospital Association and the University Health Consortium. VHA is a nationwide
Under an agreement signed at the end of last month, Philips Medical Systems will supply general radiology equipment to Novation, supplier of medical equipment to Voluntary Hospital Association and the University Health Consortium.
VHA is a nationwide network of more than 1850 community-owned healthcare organizations and physicians, while UHC is an alliance of 80 academic medical centers and 70 associate members. Novation has 5000 members, including 1500 acute-care facilities worldwide. Best, the Netherlands-based Philips will supply its general radiology systemthe Bucky Diagnost TH and TSand accessories under the three-year agreement.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
